I. Pham

1.5k citations

37 papers · 1.2k indexed · h-index 20

Impact in

Endocrine and Autonomic Systems top 5%
- Neuroscience of respiration and sleep
Cardiology and Cardiovascular Medicine top 5%
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management

Papers in ⓘ

Cardiology and Cardiovascular Medicine 15
- Cardiovascular Function and Risk Factors 8
- Cardiovascular Health and Disease Prevention 4
Endocrine and Autonomic Systems 4
- Neuroscience of respiration and sleep 4

Co-authors: Jean‐Paul Richalet (7 shared papers)A Nitenberg (7 shared papers)Emmanuel Cosson (9 shared papers)Serge Adnot (5 shared papers)M C Fournié-Zaluski (4 shared papers)Paul Valensi (6 shared papers)M Déchaux (1 shared paper)Pierre Andrivet (4 shared papers)
Journals: Diabetes & Metabolism (3 papers)European Journal of Clinical Investigation (3 papers)Journal of Cardiovascular Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)American Journal of Respiratory and Critical Care Medicine (2 papers)
Partner nations: France Tunisia United States

In The Last Decade

I. Pham

36 papers receiving 1.2k citations

Peers

Countries citing papers authored by I. Pham

Since Specialization

Citations

This map shows the geographic impact of I. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Pham more than expected).

Fields of papers citing papers by I. Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Pham. The network helps show where I. Pham may publish in the future.

Co-authors

The 25 scholars most cited alongside I. Pham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I. Pham Line = papers co-authored together I. Pham links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Sildenafil Inhibits Altitude-induced Hypoxemia and Pulmonary Hypertension American Journal of Respiratory and Critical Care Medicine ·Jean‐Paul Richalet, P Gratadour, Paul Robach, I. Pham, M Déchaux, Aude Joncquiert-Latarjet, Pascal Mollard, Julien V. Brugniaux, Jérémy Cornolo	2004	170
2	Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo American Journal of Physiology-Lung Cellular and Molecular Physiology ·I. Pham, Tokujiro Uchida, Carole Planès, Lorraine B. Ware, Robert J. Kaner, Michael A. Matthay, Christine Clérici	2002	80
3	Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats American Journal of Physiology-Heart and Circulatory Physiology ·Saadia Eddahibi, Bernadette Raffestin, I. Pham, J.M. Launay, Philippe Aegerter, M. Sitbon, Serge Adnot	1997	77
4	Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. Journal of Pharmacology and Experimental Therapeutics ·I. Pham, Walter González, Abdelaziz Amrani, M C Fournié-Zaluski, M. Philippe, I Laboulandine, B P Roques, J B Michel	1993	76
5	New Dual Inhibitors of Neutral Endopeptidase and Angiotensin-Converting Enzyme: Rational Design, Bioavailability, and Pharmacological Responses in Experimental Hypertension Journal of Medicinal Chemistry ·Marie‐Claude Fournié‐Zaluski, Pascale Coric, Serge Turcaud, Nathalie Rousselet, Walter G. Gonzalez, Brigitte Barbe, I. Pham, Nathalie Jullian, Jean‐Baptiste Michel, Bernárd P. Roques	1994	67
6	A modified Cockcroft-Gault formula taking into account the body surface area gives a more accurate estimation of the glomerular filtration rate Journal of Nephrology ·Guy Rostoker, Pierre Andrivet, I. Pham, Mireille Griuncelli, Serge Adnot	2007	63
7	Impaired Coronary Endothelium–Dependent Vasodilation Is Associated With Microalbuminuria in Patients With Type 2 Diabetes and Angiographically Normal Coronary Arteries Diabetes Care ·Emmanuel Cosson, I. Pham, Paul Valensi, Jacques Pariès, Jean-Raymond Attali, A Nitenberg	2006	61
8	Acetazolamide for Monge's Disease American Journal of Respiratory and Critical Care Medicine ·Jean‐Paul Richalet, Maria C. Rivera, Maxime Maignan, Catherine Privat, I. Pham, José Luis Macarlupú, Olivier Petitjean, Fabiola Lèon‐Velarde	2008	59
9	Pulmonary Pressure and Cardiac Function in Chronic Mountain Sickness Patients CHEST Journal ·Maxime Maignan, Maria C. Rivera, Catherine Privat, Fabiola Lèon‐Velarde, Jean‐Paul Richalet, I. Pham	2008	58
10	Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension. Proceedings of the National Academy of Sciences ·M C Fournié-Zaluski, Walter G. Gonzalez, Serge Turcaud, I. Pham, B.P. Roques, Jean‐Baptiste Michel	1994	52
11	Renal and vascular effects of C-type and atrial natriuretic peptides in humans American Journal of Physiology-Regulatory, Integrative and Comparative Physiology ·I. Pham, Saı̈d Sediame, G. Maistre, Françoise Roudot‐Thoraval, Pierre‐Etienne Chabrier, A. Carayon, Serge Adnot	1997	42
12	Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: A 10 year follow-up study Atherosclerosis ·A Nitenberg, I. Pham, I ANTONY, Paul Valensi, JR Attali, D. S. Chemla	2005	34
13	Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats. Journal of Pharmacology and Experimental Therapeutics ·W Gonzalez Vera, M C Fournié-Zaluski, I. Pham, I Laboulandine, B.P. Roques, J B Michel	1995	34
14	Postprandial endothelial dysfunction: role of glucose, lipids and insulin Diabetes & Metabolism ·A Nitenberg, Emmanuel Cosson, I. Pham	2006	33
15	Evidence for a Specific Diabetic Cardiomyopathy: An Observational Retrospective Echocardiographic Study in 656 Asymptomatic Type 2 Diabetic Patients International Journal of Endocrinology ·I. Pham, Emmanuel Cosson, M.T. Nguyen, I. Banu, Isabelle Genevois, Patricia Poignard, Paul Valensi	2015	29
16	L-Arginine Supplementation Alleviates Postprandial Endothelial Dysfunction When Baseline Fasting Plasma Arginine Concentration Is Low: A Randomized Controlled Trial in Healthy Overweight Adults with Cardiometabolic Risk Factors Journal of Nutrition ·Ambre Deveaux, I. Pham, Sheila G. West, Étienne André, Frédérique Lantoine‐Adam, Pierre Bunouf, Samira Sadi, Dominique Hermier, Véronique Mathé, Hélène Fouillet, Jean‐François Huneau, Robert Benamouzig, François Mariotti	2016	26
17	Increased erythropoietin synthesis in patients with COLD or left heart failure is related to alterations in renal haemodynamics European Journal of Clinical Investigation ·I. Pham, Pierre Andrivet, Saı̈d Sediame, C. Defouilloy, Stéphane Moutereau, V Wirquin, C. Chouaïd, B. Housset, S. Adnot	2001	26
18	Endothelin receptors blockade blunts hypoxia‐induced increase in PAP in humans European Journal of Clinical Investigation ·I. Pham, Grégoire Wuerzner, Jean‐Paul Richalet, S. Peyrard, Michel Azizi	2010	24
19	N‐terminal pro‐B‐type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients Diabetic Medicine ·Emmanuel Cosson, M.T. Nguyen, I. Pham, Michel Pontet, A Nitenberg, P. Valensi	2009	23
20	Effects of the Selective Neutral Endopeptidase Inhibitor, Retrothiorphan, on Renal Function and Blood Pressure in Conscious Normotensive Wistar and Hypertensive DOCA-Salt Rats Journal of Cardiovascular Pharmacology ·I. Pham, A-I K El Amrani, M C Fournié-Zaluski, Pierre Corvol, B.P. Roques, J B Michel	1992	20

About I. Pham

I. Pham is a scholar working on Cardiology and Cardiovascular Medicine, Endocrine and Autonomic Systems, Nephrology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (8 papers), Cardiac Imaging and Diagnostics (7 papers), High Altitude and Hypoxia (6 papers), Peptidase Inhibition and Analysis (4 papers), Neuropeptides and Animal Physiology (4 papers), Neuroscience of respiration and sleep (4 papers), Cardiovascular Health and Disease Prevention (4 papers) and Cardiovascular and Diving-Related Complications (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (187 citations), Cardiology and Cardiovascular Medicine (450 citations), Nephrology (90 citations), Pulmonary and Respiratory Medicine (325 citations) and Endocrinology, Diabetes and Metabolism (154 citations). I. Pham has collaborated with scholars based in France, Tunisia and United States. Frequent co-authors include Jean‐Paul Richalet, A Nitenberg, Emmanuel Cosson, Serge Adnot, M C Fournié-Zaluski, Paul Valensi, M Déchaux, Pierre Andrivet, Jérémy Cornolo and P Gratadour. Their work appears in journals such as Diabetes & Metabolism, European Journal of Clinical Investigation, Journal of Cardiovascular Pharmacology, Journal of Pharmacology and Experimental Therapeutics and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact